Calcium‐Polyphenol Functionalized Black Phosphorus Nanosheet System for Osteoporosis Therapy via Macrophage Reprogramming and Bone Microenvironment Remodeling
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202504217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xueqiang Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, P. R. China. Hauptthemen laut MEDLINE: Osteoporosis, Macrophages, Polyphenols, Calcium. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Project of the State Administration of Traditional Chinese Medicine, Jiangxi Province Key Laboratory of Precision Cell Therapy.
Abstract (Originalsprache)
Osteoporosis poses a significant threat to human health and severely impairs patients' quality of life. Conventional pharmacological interventions are limited by poor patient compliance and suboptimal efficacy. Imbalanced macrophage polarization is a key driver in osteoporosis pathogenesis, and precise regulation toward the anti‐inflammatory M2 phenotype represents a critical therapeutic target. A calcium‐polyphenol network‐functionalized black phosphorus nanosheet system (HCBP) is developed as a bone‐targeted cascade‐responsive nanoplatform. After intravenous administration, bone‐targeting peptides mediate efficient accumulation in bone tissue. The system dissociates in the acidic osteoporotic microenvironment and releases phosphate ions, which combine with calcium ions to form bioactive calcium phosphate. HCBP alleviates inflammation, sustains M2 macrophage polarization, scavenges reactive oxygen species, enhances osteogenesis, and suppresses osteoclast differentiation. Transcriptomic analysis confirms regulation of the TNF‐α/NF‐κB, IL‐17, and osteoclast differentiation pathways, together with inhibited glycolysis. This multifunctional strategy overcomes the limitations of single‐target osteoporosis therapies and facilitates the clinical translation of nanomedicines for metabolic bone diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, P. R. China.
- Jiangxi Province Key Laboratory of Precision Cell Therapy, The Institute of Translational Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P. R. China.
- Department of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, P. R. China.
ORCID-Profile: Jun Luo
Förderung
- National Natural Science Foundation of China
- Key Research and Development Project of the State Administration of Traditional Chinese Medicine
- Jiangxi Province Key Laboratory of Precision Cell Therapy
Zitieren
APA
Deng, X., Li, Z., Yi, X., Ruan, D., Chen, X., & Luo, J. (2026). Calcium‐Polyphenol Functionalized Black Phosphorus Nanosheet System for Osteoporosis Therapy via Macrophage Reprogramming and Bone Microenvironment Remodeling. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504217
Vancouver
Deng X, Li Z, Yi X, Ruan D, Chen X, Luo J. Calcium‐Polyphenol Functionalized Black Phosphorus Nanosheet System for Osteoporosis Therapy via Macrophage Reprogramming and Bone Microenvironment Remodeling. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504217
BibTeX
@article{Deng2026,
author = {Deng, Xueqiang and Li, Zhiqiang and Yi, Xuan and Ruan, Dong and Chen, Xiang and Luo, Jun},
title = {Calcium‐Polyphenol Functionalized Black Phosphorus Nanosheet System for Osteoporosis Therapy via Macrophage Reprogramming and Bone Microenvironment Remodeling},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202504217}
}
EUVIMED